147 related articles for article (PubMed ID: 33761731)
1. Genetic factors and the risk of drug-resistant epilepsy in young children with epilepsy and neurodevelopment disability: A prospective study and updated meta-analysis.
Lin CH; Chou IC; Hong SY
Medicine (Baltimore); 2021 Mar; 100(12):e25277. PubMed ID: 33761731
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for drug-resistant epilepsy: A systematic review and meta-analysis.
Xue-Ping W; Hai-Jiao W; Li-Na Z; Xu D; Ling L
Medicine (Baltimore); 2019 Jul; 98(30):e16402. PubMed ID: 31348240
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis.
Sultana B; Panzini MA; Veilleux Carpentier A; Comtois J; Rioux B; Gore G; Bauer PR; Kwon CS; Jetté N; Josephson CB; Keezer MR
Neurology; 2021 Apr; 96(17):805-817. PubMed ID: 33722992
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis.
Kalilani L; Sun X; Pelgrims B; Noack-Rink M; Villanueva V
Epilepsia; 2018 Dec; 59(12):2179-2193. PubMed ID: 30426482
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of drug-resistant-epilepsy and its associated factors in patients with epilepsy.
Mohammadzadeh P; Nazarbaghi S
Clin Neurol Neurosurg; 2022 Feb; 213():107086. PubMed ID: 35063723
[TBL] [Abstract][Full Text] [Related]
6. Preoperative evaluation and surgical management of infants and toddlers with drug-resistant epilepsy.
Pindrik J; Hoang N; Smith L; Halverson M; Wojnaroski M; McNally K; Gedela S; Ostendorf AP
Neurosurg Focus; 2018 Sep; 45(3):E3. PubMed ID: 30173613
[TBL] [Abstract][Full Text] [Related]
7. Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants.
Symonds JD; Elliott KS; Shetty J; Armstrong M; Brunklaus A; Cutcutache I; Diver LA; Dorris L; Gardiner S; Jollands A; Joss S; Kirkpatrick M; McLellan A; MacLeod S; O'Regan M; Page M; Pilley E; Pilz DT; Stephen E; Stewart K; Ashrafian H; Knight JC; Zuberi SM
Brain; 2021 Oct; 144(9):2879-2891. PubMed ID: 34687210
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of drug-resistant epilepsy in children presenting under 2 years of age: experience of a tertiary center in Turkey.
Yildiz EP; Gunes D; Bektas G; Aksu Uzunhan T; Tatli B; Caliskan M; Aydinli N; Ozmen M
Acta Neurol Belg; 2018 Mar; 118(1):71-75. PubMed ID: 29063291
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Drug-resistant Epilepsy (DRE) and a nomogram model to predict DRE development in post-traumatic epilepsy patients.
Yu T; Liu X; Sun L; Lv R; Wu J; Wang Q
CNS Neurosci Ther; 2022 Oct; 28(10):1557-1567. PubMed ID: 35822252
[TBL] [Abstract][Full Text] [Related]
10. Neurocysticercosis: An uncommon cause of drug-refractory epilepsy in North Indian population.
Goyal M; Chand P; Modi M; Khandelwal N; Kharbanda PS; Lal V; Singla V; Sehgal R
Epilepsia; 2015 Nov; 56(11):1747-52. PubMed ID: 26513213
[TBL] [Abstract][Full Text] [Related]
11. Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011-2021.
Shankar R; Marston XL; Danielson V; Do Rego B; Lasagne R; Williams O; Groves L
J Neurol; 2024 May; 271(5):2473-2483. PubMed ID: 38240828
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in epileptic encephalopathies at onset in the first 2 years of life: The experience of a tertiary healthcare center in Italy.
Pellino G; Chiavarino F; Fiumana E; Boni A; Russo A; Faggioli R
Epilepsy Behav; 2019 Oct; 99():106465. PubMed ID: 31421519
[TBL] [Abstract][Full Text] [Related]
13. Drug-resistant epilepsy in Indian children at a tertiary-care public hospital.
Kharod P; Mishra D; Juneja M
Childs Nerv Syst; 2019 May; 35(5):775-778. PubMed ID: 30758667
[TBL] [Abstract][Full Text] [Related]
14. A population-based study of active and drug-resistant epilepsies in Northern Italy.
Giussani G; Canelli V; Bianchi E; Franchi C; Nobili A; Erba G; Beghi E;
Epilepsy Behav; 2016 Feb; 55():30-7. PubMed ID: 26731716
[TBL] [Abstract][Full Text] [Related]
15. Predicting drug resistance in adult patients with generalized epilepsy: A case-control study.
Voll A; Hernández-Ronquillo L; Buckley S; Téllez-Zenteno JF
Epilepsy Behav; 2015 Dec; 53():126-30. PubMed ID: 26561950
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing improves treatment efficacy and reduces hospitalization in children with drug-resistant epilepsy.
Peng J; Pang N; Wang Y; Wang XL; Chen J; Xiong J; Peng P; Zhu CH; Kessi MB; He F; Yin F
CNS Neurosci Ther; 2019 Jan; 25(1):14-20. PubMed ID: 29933521
[TBL] [Abstract][Full Text] [Related]
17. Multivariable prediction model of drug resistance in adult patients with generalized epilepsy from Colombia: A case-control study.
Orozco-Hernández JP; Quintero-Moreno JF; Marín-Medina DS; Valencia-Vásquez A; Villada HC; Lizcano A; Martínez JW
Epilepsy Behav; 2018 Nov; 88():176-180. PubMed ID: 30290326
[TBL] [Abstract][Full Text] [Related]
18. Variable patterns of mutation density among NaV1.1, NaV1.2 and NaV1.6 point to channel-specific functional differences associated with childhood epilepsy.
Encinas AC; Watkins JC; Longoria IA; Johnson JP; Hammer MF
PLoS One; 2020; 15(8):e0238121. PubMed ID: 32845893
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of deep brain stimulation for the treatment of drug-resistant epilepsy in childhood.
Yan H; Toyota E; Anderson M; Abel TJ; Donner E; Kalia SK; Drake J; Rutka JT; Ibrahim GM
J Neurosurg Pediatr; 2018 Nov; 23(3):274-284. PubMed ID: 30544364
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy.
Skjei KL; Church EW; Harding BN; Santi M; Holland-Bouley KD; Clancy RR; Porter BE; Heuer GG; Marsh ED
J Neurosurg Pediatr; 2015 Dec; 16(6):668-74. PubMed ID: 26339958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
